Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 2:13:847113.
doi: 10.3389/fphar.2022.847113. eCollection 2022.

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review

Christine Yen  1   2 , Fan Zhao  1   3 , Zhichao Yu  1   4 , Xiaoshu Zhu  1   2   5 , Chun Guang Li  5
Affiliations
Review

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review

Christine Yen et al. Front Pharmacol. .

Abstract

Introduction: Tamoxifen (TAM) is the most commonly used hormone therapeutic drug for the treatment of estrogen receptor-positive (ER+) breast cancer. 30%-70% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions. Objective: To evaluate the evidence for the interactions between natural products and TAM in breast cancer. Methods: Electronic databases, including PubMed, CINAHL Plus (via EbscoHost), European PMC, Medline, and Google Scholar, were searched for relevant publications. The search terms include complementary and alternative medicine, natural products, plant products, herbs, interactions, tamoxifen, breast cancer, and their combinations. Results: Various in vitro and in vivo studies demonstrated that the combined use of natural products with TAM produced synergistic anti-cancer effects, including improved inhibition of tumor cell growth and TAM sensitivity and reduced side effects or toxicity of TAM. In contrast, some natural products, including Angelica sinensis (Oliv.) Diels [Apiaceae], Paeonia lactiflora Pall., Rehmannia glutinosa (Gaertn.) DC., Astragalus mongholicus Bunge, and Glycyrrhiza glabra L. [Fabaceae], showed estrogen-like activity, which may reduce the anti-cancer effect of TAM. Some natural products, including morin, silybin, epigallocatechin gallate (EGCG), myricetin, baicalein, curcumin, kaempferol, or quercetin, were found to increase the bioavailability of TAM and its metabolites in vivo. However, three are limited clinical studies on the combination of natural products and TAM. Conclusion: There is evidence for potential interactions of various natural products with TAM in pre-clinical studies, although the relevant clinical evidence is still lacking. Further studies are warranted to evaluate the potential interactions of natural products with TAM in clinical settings.

Keywords: breast cancer; herbal medicines; interactions; mechanisms; natural products; pharmacodynamic; pharmacokinetic; tamoxifen.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ali S., Rasool M., Chaoudhry H., N Pushparaj P., Jha P., Hafiz A., et al. (2016). Molecular Mechanisms and Mode of Tamoxifen Resistance in Breast Cancer. Bioinformation 12 (3), 135–139. 10.6026/97320630012135 - DOI - PMC - PubMed
    1. Atashrazm F., Lowenthal R. M., Woods G. M., Holloway A. F., Dickinson J. L. (2015). Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential. Mar. Drugs 13 (4), 2327–2346. 10.3390/md13042327 - DOI - PMC - PubMed
    1. Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. (2005). p62/SQSTM1 Forms Protein Aggregates Degraded by Autophagy and Has a Protective Effect on Huntingtin-Induced Cell Death. J. Cel. Biol. 171 (4), 603–614. 10.1083/jcb.200507002 - DOI - PMC - PubMed
    1. Boon H. S., Olatunde F., Zick S. M. (2007). Trends in Complementary/Alternative Medicine Use by Breast Cancer Survivors: Comparing Survey Data from 1998 and 2005. BMC Womens Health 7, 4. 10.1186/1472-6874-7-4 - DOI - PMC - PubMed
    1. Bracke M. E., Depypere H. T., Boterberg T., Van Marck V. L., Vennekens K. M., Vanluchene E., et al. (1999). Influence of Tangeretin on Tamoxifen's Therapeutic Benefit in Mammary Cancer. J. Natl. Cancer Inst. 91 (4), 354–359. 10.1093/jnci/91.4.354 - DOI - PubMed

LinkOut - more resources